Reaction

Cerebral Toxoplasmosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 923 reports · 74 co-occurring drugs

As of the last recalculation, Cerebral Toxoplasmosis appears in 923 FAERS reports alongside 74 co-occurring drug terms. The strongest observed disproportionality signal is BUSULFAN (PRR 106.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Busulfan	69	106.8	107.3
Anti-Thymocyte Globulin (Rabbit)	28	80.7	81.0
Fludarabine Phosphate	122	80.5	80.7
Mycophenolate Mofetil Hydrochloride	287	68.6	68.7
Mycophenolate Mofetil	286	68.4	68.5
Thiotepa	28	68.2	68.4
Posaconazole Delayed-Release	30	63.6	63.8
Lopinavir And Ritonavir	34	58.7	58.8
Melphalan	55	57.9	58.1
Melphalan Hydrochloride	58	55.6	55.7
Mesna Injection	19	52.9	53.0
Ganciclovir	23	51.9	52.1
Mesna	19	51.9	52.1
Ganciclovir Sodium	23	50.2	50.3
Atovaquone	17	48.5	48.6
Posaconazole	31	44.5	44.6
Valganciclovir Hydrochloride Powder,	23	43.6	43.7
Efavirenz	21	43.4	43.5
Imatinib	31	41.0	41.1
Abacavir Sulfate	17	40.1	40.1
Lamivudine	50	38.5	38.6
Mycophenilic Acid	34	38.4	38.4
Tacrolimus Ointment 0.1%	169	37.2	37.3
Tacrolimus Extended-Release Capsules	169	37.1	37.2
Lamivudine Oral	38	35.3	35.3
Zidovudine	20	34.5	34.5
Sirolimus	20	34.2	34.2
Valganciclovir	26	32.0	32.0
Valganciclovir Hydrochloride	26	32.0	32.0
Tacrolimus	179	31.7	31.8
Fluconazole	87	30.8	30.8
Atazanavir	19	30.4	30.5
Basiliximab	15	29.2	29.3
Pyrazinamide	12	29.2	29.2
Mycophenolic Acid	36	26.4	26.4
Cyclosporine	114	26.2	26.2
Ritonavir 100 Mg	17	26.1	26.2
Carfilzomib	30	24.7	24.7
Clindamycin	29	23.8	23.8
Cyclophosphamide Injection, Solution	150	22.6	22.6
Cyclophosphamide	150	22.6	22.6
Cyclophosphamide For Injection	150	22.6	22.6
Raltegravir	16	22.2	22.2
Bendamustine Hcl	15	22.2	22.2
Ritonavir	27	21.4	21.5
Isoniazid	15	21.2	21.2
Tenofovir Disoproxil Fumarate Tablets	8	21.1	21.1
Cytarabine	53	21.0	21.1
Daspone	9	21.0	21.1
Dapsone Gel, 5%	9	21.0	21.0
Thalidomide	32	20.3	20.3
Clindamycin Phosphate	29	20.2	20.2
Dapsone	9	19.2	19.2
Daratumumab	31	18.1	18.1
Dexamethasone Sodium Phosphate	8	17.9	17.9
Baricitinib	7	16.5	16.5
Amphotericin B	9	16.3	16.4
Rituximab	128	15.7	15.7
Leucovorin Calcium	13	15.5	15.6
Dolutegravir Sodium	6	15.1	15.1
Nevirapine	6	15.1	15.1
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	11	13.8	13.8
Bendamustine Hydrochloride	7	13.3	13.3
Etoposide	40	12.8	12.8
Doxorubicin	48	12.8	12.8
Doxorubicin Hydrochloride	16	11.2	11.2
Tenofovir Disoproxil Fumarate	16	11.1	11.1
Emtricitabine And Tenofovir Alafenamide	5	10.0	10.0
Emtricitabine And Tenofovir Disoproxil Fumarate	18	9.1	9.1
Brentuximab Vedotin	4	8.8	8.8
Eltrombopag Olamine	8	7.9	7.9
Dasatinib	12	7.4	7.4
Pomalidomide	26	5.8	5.8
Sarilumab	5	4.3	4.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.